Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies
Open Access
- 12 April 2005
- journal article
- research article
- Published by Springer Nature in Molecular Psychiatry
- Vol. 10 (8) , 765-770
- https://doi.org/10.1038/sj.mp.4001664
Abstract
There is strong evidence for a genetic contribution to schizophrenia, but the contribution of individual candidate genes remains uncertain. We attempted to replicate a recent meta-analysis that reported an association of the catechol O-methyltransferase (COMT) Val allele with schizophrenia, and suggested that this effect may be moderated by ancestry. We included reports published subsequent to the original meta-analysis, and included a formal test of the moderating effect of ancestry in order to test whether the association operates differently in populations of European ancestry compared to populations of Asian ancestry. A corrected P-value for the 5% significance threshold was employed where appropriate, using Bonferroni's method, and studies that demonstrated departure from Hardy–Weinberg equilibrium among controls were excluded. When all studies were included in a meta-regression, there was evidence for a significant association of COMT Val allele frequency with schizophrenia case status and a significant main effect of ancestry. The interaction of COMT Val allele frequency and ancestry was also significant. However, when only studies that reported allele frequencies that did not depart significantly from Hardy–Weinberg equilibrium among controls were included, these effects were no longer significant. The results of our meta-analysis do not support an association between the COMT Val allele and schizophrenia case status, and do not support recent claims that this association may be moderated by ancestry.Keywords
This publication has 26 references indexed in Scilit:
- Genetic Linkage for Schizophrenia?American Journal of Psychiatry, 2004
- Association between Val108/158met polymorphism of theCOMTgene and schizophreniaAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Relationship between catechol‐O‐methyltransferase polymorphism and treatment‐resistant schizophreniaAmerican Journal Of Medical Genetics Part B-Neuropsychiatric Genetics, 2003
- Association Between a Functional CatecholO-Methyltransferase Gene Polymorphism and Schizophrenia: Meta-Analysis of Case-Control and Family-Based StudiesAmerican Journal of Psychiatry, 2003
- Functional catechol-O-methyltransferase gene polymorphism and susceptibility to schizophreniaEuropean Neuropsychopharmacology, 2002
- Schizophrenia and functional polymorphisms in the MAOA and COMT genes: No evidence for association or epistasisAmerican Journal of Medical Genetics, 2002
- Homicidal behavior in schizophrenia associated with a genetic polymorphism determining low catechol O-methyltransferase (COMT) activityAmerican Journal of Medical Genetics, 1999
- Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disordersPharmacogenetics, 1996
- Kinetics of Human Soluble and Membrane-Bound Catechol O-Methyltransferase: A Revised Mechanism and Description of the Thermolabile Variant of the EnzymeBiochemistry, 1995
- The current status of the dopamine hypothesis of schizophreniaNeuropsychopharmacology, 1988